Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy.

Autor: Wilk AJ; Division of Infectious Diseases and Geographic Medicine, Department of Medicine.; Program in Immunology.; Medical Scientist Training Program., Weidenbacher NL; Department of Chemistry., Vergara R; Division of Infectious Diseases and Geographic Medicine, Department of Medicine., Haabeth OAW; Division of Oncology, Department of Medicine., Levy R; Division of Oncology, Department of Medicine., Waymouth RM; Department of Chemistry., Wender PA; Department of Chemistry.; Department of Chemical and Systems Biology, Stanford University, Stanford, CA; and., Blish CA; Division of Infectious Diseases and Geographic Medicine, Department of Medicine.; Chan Zuckerberg Biohub, San Francisco, CA.

Publikováno v: Blood advances [Blood Adv] 2020 Sep 08; Vol. 4 (17), pp. 4244-4255.